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Abstract
Hemorrhagic fever with renal syndrome (HFRS) is
caused by the Hanta viruses. a group enveloped RNA
viruses transmitted through contact with infected
rodent urine or feces. Although distributed widely
through Europe. Asia. and the New World. infections
acquired in Korea, China, and Russia tend to be
among the most severe, The initial presentation of
HFRS is extremely variable, but generally includes
fever, malaise, headache and abdominal pain.
Laboratory findings that may lead to the diagnosis
include thrombocytopenia, azotemia, elevated serum
creatinine, or proteinuria. We present the case of
a patient that acquired hemorrhagic fever with renal
syndrome in South Korea.
Introduction
During the Korean War, United Nations troops were
affected by an acute febrile illness associated with
renal failure. thrombocytopenia. and hemorrhages:
similarillnesses hadbeen described in Chinese medical
writings as early as 960 AD. During the Korean War.
researchers were able to demonstrate the infective
nature of the illness and suspected a rodent vector, but
the etiologic agent remained obscure. ‘The disease is
now known as hemorrhagic fever with renal syndrome
and is known to be caused by the Hantaviruses, a fam
ily of enveloped RNA viruses. Transmission occurs
through inhalation of aerosol ized rodent excreta and
symptoms begin I-S weeks after exposure.
Case Report
A 19-year-old previously healthy woman serving
in the US Army was stationed in Korea and went to
conduct field-training exercises with her unit. Dur
ing the exercises, the patient spent most of her time
riding in vehicles and slept in an old wooden barracks
at night. No signs of rodent inhabitation were noted
during her stay. On the tenth day of the exercise, she
began to experience an intense headache and blurry
vision. Over the next several days, her symptoms
expanded to include fever, fatigue. abdominal pain, and
myalgias. She sought medical care numerous times
and was diagnosed as having migraines. dehydration.
or a viral syndrome.
Fourteen days after the start of the field exercises.
she was admitted to the hospital after developing
acute renal failure. On admission, she was febrile
to 101.3°F and as noted to have periorbital and
extremity edema: platelets were 79 x I OIL, serum
creatinine was 1.3 mgldL. and urine dipstick showed
3+ proteinuria. The patient remained in Korea until
her creatinine rose to 4.9 mgldL. at which time she
was transferred to Tripler Army Medical Center in
Hawaii. Shortly before transfer, serology returned
positive for Hantaan virus 1gM and the patient was
started on IV ribavirin. On arrival at Tripler. the
patient’s platelet count was 257 x l0’/L. her serum
creatinine remained 4.9 mg/dL, and she continued to
appear edematous. IV rihavirin was discontinued
and the patient underwent a brisk auto—diuresis. She
reco ered uneventfully with only supportive care and
was discharged from the hospital twenty-two days
after her field exercise began. Her serum creatinine
was 1.2 mgldL on discharge.
Discussion
Approximately 150,000 people are hospitalized each
year due to clinical illness from Hantavirus infection,
predominately in Korea, China, and Eastern Russia.
The case-mortality ratio for HFRS in this region is
approximately 5-10%. When suspected clinically,
the diagnosis of l’IFRS is confirmed with serology.
A positive 1gM or a four—fold rise in Hantavirus IgG
titer confirms Hantavirus infection.
HFRS is classically divided into live sequential but
overlapping phases: Febrile. hypotensive. oliguric.
diuretic. and cons alescent. During the initial febrile
phase. patients v ith HRFS tvpicalh preselfl with
abrupt onsetof fe er and chills, lethargy. and weakness.
which may later he accompanied by dizziness, thirst,
anorexia, myalgias. and abdominal pain. Physical
exam may initially he notable forconjunctival injection
or pharyngeal erythema. Laboratory studies are usu
ally normal at this point. Then patients progress into
the hypotensive phase. In addition to a drop in blood
pressure, patients’ platelet counts and renal function
decrease and proteinuria develops. Some patients may
progress to shock. The disease then progresses to the
oliguric phase. characterizedbv difficulties regulating
electrolytes and volume status, potentially leading to
pulmonary edema. Although platelet counts begin to
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recover in the ohguric phase, patients are most prone
to hemorrhage at this point, including gastrointestinal
or retroperitoneal hemorrhage. The diuretic phase
is marked by a return of renal function, but can be
complicated by electrolyte abnormalities as fluid shifts
occur. During the convalescent phase, renal function
continues to improve.2 An important marker in the
course of HFRS is the patient’s platelet count; a nor
malization of the platelet count heralds the return of
renal function.3 In this case, the patient from Korea
had a normal platelet count on arrival in Hawaii, which
was a very good prognostic indicator.
Major causes of mortality in HFRS are related to
shock, electrolyte abnormalities, pulmonary edema
and hemorrhage. The underlying pathophysiologic
abnormality is thought to be endothelial dysfunction.4
Treatment is generally supportive: cautious use of IV
fluids or pressors for hypotension, hemodialysis if
indicated for volume overload, administration ofblood
products, and treatment of electrolyte disturbances.
Intravenous ribavirin exists as a specific treatment
for hemorrhagic fever with renal syndrome. although
it is still experimental at the current time. In a study
conducted in China, intravenous ribavirin given within
six days of the onset of symptoms significantly re
duced the mortality associated with HFRS. Most of
the benefit of ribavirin appears to be associated with
a reduction in the risk of entering the oliguric phase.
The only side effect noted with ribavirin was a mild
hemolytic anemia, which reversed with cessation
of drug therapy.5 In this case, the patient arrived in
Hawaii eight days after the onset of her symptoms and
already appeared to be recovering, so the ribavirin was
not continued after she was transferred.
Conclusion
The diagnosis of hemorrhagic fever with renal syn
drome should be entertained in any patient with a
febrile illness and travel to an endemic area, especially
ifassociated with severe malaise, headache, myalgias,
or abdominal pain. Common screening laboratory
stud ies, such as a complete blood count, chemistries.
or urinalysis, may show thrombocytopenia, renal
failure or proteinuria, offering a clue to the diagnosis.
Hantavirus serologies can confirm the diagnosis of
I-IFRS. Treatment is generally supportive, but IV
ribavirin may be beneficial if initiated early in the
course of the disease.
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Figure 1.— Serum creatinine and platelet count after start of field exercise
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